A 2025 study found that people prescribed semaglutide or tirzepatide were diagnosed with certain balance and vertigo disorders more often than similar people who did not use a GLP-1 medication.
Later, a 2026 study found that adults with type 2 diabetes who started a GLP-1 drug were slightly more likely to later receive repeated diagnoses for dizziness, inner-ear balance disorders, or hearing problems than similar adults who started certain other diabetes drugs.
Dizziness is a documented side effect of some GLP-1 products, but evidence connecting these drugs directly to vertigo and other vestibular disorders is still limited. Below, we explain what current research shows, which symptoms need prompt attention, and what steps you can take next.
Quick answer
GLP-1 medications are known to cause dizziness in some users. In adult weight-loss trials, dizziness occurred in 8% of people taking Wegovy versus 4% taking a placebo, and in 4% to 5% of people taking Zepbound versus 2% taking a placebo. However, these figures cover dizziness of any kind, but not specifically vertigo.
Two large studies published in 2025 and 2026 found that GLP-1 users were diagnosed with vertigo and balance problems more often than people who did not use these drugs. However, the results were very different between the two studies, and neither study proved that GLP-1 medications were the cause. A connection may exist, but the overall risk of developing a diagnosed balance disorder still appears to be low.
Can GLP-1 drugs cause vertigo?
They may contribute to vertigo in a small number of people, but the evidence does not yet show a direct cause-and-effect relationship. Dizziness is listed in current FDA prescribing information for several GLP-1 medicines, while true vertigo is not given its own common-side-effect rate.
Studies about GLP-1 drugs and vertigo
Published in Biomedicines in April 2025, the study used the TriNetX electronic health record network. It included 419,497 semaglutide users and 77,259 tirzepatide users treated between January 2018 and October 2024. Each medication group was matched with people who had similar health characteristics but had not used a GLP-1 drug.
The researchers found an association between semaglutide or tirzepatide use and new vestibular disorder diagnoses. Vestibular refers to the inner-ear and brain systems that help control balance, eye movements, and the sense of where the body is in space.
After six months, 0.12% of semaglutide users had been diagnosed with a vestibular or balance disorder, compared with 0.03% of people in the control group. After three years, the rates were 0.41% and 0.16%.
After six months, 0.10% of tirzepatide users had received a vestibular diagnosis, compared with 0.04% of controls. After three years, the rates were 0.19% and 0.15%.
Among GLP-1 users who developed a vestibular disorder, benign paroxysmal positional vertigo, or BPPV, made up 67.3% of cases. BPPV was more common among semaglutide users, while central vertigo made up a larger share of cases among tirzepatide users.
A 2026 study also found more vestibular disorders and dizziness among GLP-1 users.
Published in the International Journal of Medical Sciences on March 17, 2026, this study included adults with type 2 diabetes in the US TriNetX network. Researchers matched 342,046 GLP-1 users with 342,046 people starting either a DPP-4 inhibitor or an SGLT2 inhibitor.
The study found:
|
Outcome |
GLP-1 group |
Comparison group |
| Peripheral vestibular disorder |
4,407 cases |
3,946 cases |
| Dizziness |
32,545 cases |
29,931 cases |
| Hearing impairment |
9,522 cases |
7,898 cases |
After one year, 0.29% of GLP-1 users had been diagnosed with a peripheral vestibular disorder, compared with 0.28% of people in the comparison group. Dizziness was reported in 2.51% of GLP-1 users and 2.40% of the comparison group.
The differences were small, and the study could not prove that GLP-1 medications caused these problems.
In addition, its participants had type 2 diabetes, so the results may not apply in the same way to someone using a GLP-1 drug only for obesity.
What GLP-1 users said about dizziness and vertigo on Reddit
A Reddit post came from a tirzepatide community and asked whether other users had experienced dizziness or true vertigo while taking the medication.
The person who created the post said they had been using compounded tirzepatide for about six months and had recently developed dizziness that lasted more than a day and continued to come and go. They had experienced brief vertigo episodes years earlier, but the new symptoms felt different and were concerning. They were especially worried because they knew someone whose vertigo continued for months after stopping treatment.
Most of the replies described lightheadedness rather than confirmed inner-ear vertigo. Several users said they felt dizzy when standing up, bending down, stretching, or getting out of bed. Some said they felt close to fainting. These symptoms were often described as orthostatic hypotension, which is a drop in blood pressure when a person changes position.
A number of commenters believed low blood pressure was contributing to their symptoms. Some had lost enough weight that their existing blood pressure medication became too strong and had to be reduced. Others were taking medications such as spironolactone, which can also lower blood pressure. Several users said their dizziness improved after their medication dose was reviewed.
Dehydration, low sodium, and other electrolyte problems were also common. Some users said they felt better after drinking electrolyte beverages, eating more regularly, or increasing their salt intake. One person reported that testing in the emergency room showed low potassium. Another said low blood sugar appeared to be the likely cause of a severe episode.
Comment
byu/knobsalot from discussion
intirzepatidecompound
Several users noticed that the symptoms became worse after increasing their tirzepatide dose. One person said dizziness started after moving from 7.5 mg to 10 mg and lasted about two days. Another said the problem became frequent at a higher dose but improved after reducing the amount taken. Others reported that dizziness was most noticeable during the first week after a dose increase.
A smaller number of users described symptoms that sounded more like vertigo. One person said the spinning sensation appeared when rolling over in bed.
Some commenters already had a history of dizziness or vertigo before starting tirzepatide and felt the medication made it worse. Others said their episodes were brief and eventually settled down. One user reported that the symptoms became much less noticeable over time, while another described a friend whose vertigo improved but did not fully disappear after semaglutide use.
What is the difference between dizziness, vertigo, and a balance problem?
Dizziness is an umbrella term. Vertigo is one type of dizziness in which you feel as if you or your surroundings are moving or spinning. A balance problem may feel like swaying, veering, or walking on an uneven floor even when nothing is moving.
MedlinePlus separates dizziness into lightheadedness and vertigo. Lightheadedness is the feeling that you may faint. Vertigo is the false sensation that you or the world around you is moving.
One common form of true vertigo is benign paroxysmal positional vertigo, or BPPV. It often causes short bursts of spinning when someone rolls over, lies back, looks upward, or sits up in bed. Mayo Clinic notes that head-position changes commonly trigger BPPV.
During a consultation with your clinician, instead of saying only “I feel dizzy,” explain whether the room spins, you feel close to fainting, or you cannot walk straight. Mention the trigger and how long each spell lasts.
How common is dizziness with GLP-1 drugs?
Dizziness rates vary by product, dose, study, and patient group.
|
Medication |
Active ingredient | Dizziness in treatment group |
Dizziness in placebo group |
| Wegovy |
Semaglutide |
8% |
4% |
| Ozempic |
Semaglutide |
More than 0.4% |
Not common |
| Zepbound |
Tirzepatide |
4% to 5% |
2% |
| Mounjaro |
Tirzepatide |
Not common |
Not common |
| Saxenda |
Liraglutide |
6.9% |
5% |
| Victoza |
Liraglutide |
Not common |
Not common |
| Trulicity |
Dulaglutide |
Not common |
Not common |
In Wegovy’s adult weight-reduction trials, 8% of treated participants reported dizziness compared with 4% receiving placebo. The same label reports blood-pressure-related reactions in 1.3% versus 0.4%, and fainting in 0.8% versus 0.2%.
In Zepbound trials, dizziness occurred in 4%, 5%, and 4% of people taking 5 mg, 10 mg, and 15 mg, respectively, versus 2% with placebo. Hypotension occurred in 1% to 2% of treated participants and 0% with placebo.
Again, these figures describe broad dizziness. They do not tell us how many participants experienced room-spinning vertigo.
Why might a GLP-1 drug make you dizzy or unsteady?
Several pathways can produce dizziness during GLP-1 treatment.
1. Dehydration from nausea, vomiting, or diarrhea
When the body loses fluid, the amount of blood circulating through the blood vessels drops. This can lower blood pressure and briefly reduce blood flow to the brain, particularly when standing up after sitting or lying down. A person may feel lightheaded, weak, unsteady, or close to fainting. This is often called orthostatic dizziness or orthostatic hypotension.
This type of dizziness usually feels different from true vertigo. Dehydration more often causes a faint, woozy, or unsteady feeling, while vertigo creates the sensation that the person or the room is spinning.
2. Low blood sugar
Low blood sugar can make someone feel dizzy because the brain depends on glucose for energy. When the glucose level drops, the body releases stress hormones to bring it back up. These hormones can cause sweating, shaking, a fast heartbeat, nervousness, and lightheadedness.
GLP-1 medications do not usually cause severe low blood sugar when taken alone. The risk is higher in people who also use insulin or medications called sulfonylureas. Eating very little, skipping meals, exercising more than usual, or having vomiting or diarrhea may also make a drop in blood sugar more likely.
Low blood sugar usually causes a woozy, weak, shaky, or faint feeling rather than the spinning sensation associated with true vertigo. Symptoms may improve after consuming a fast-acting source of sugar, but the blood sugar level should be checked when possible.
3. A true vestibular disorder
The 2025 and 2026 studies raise the possibility of a direct or indirect effect on balance pathways. Researchers have proposed changes in autonomic responses, inner-ear blood flow, fluid balance, or brain pathways involved in balance.
If spinning is triggered by rolling over or moving the head, BPPV may be responsible. Ear fullness, ringing, or hearing change can point toward another inner-ear problem.
How can you tell what may be causing your symptoms?
Note what you were doing when the feeling began, the exact sensation, its duration, and any symptoms that appeared with it.
|
Pattern |
Possible explanation |
What to do |
| Brief spinning when rolling over, looking up, or lying back | BPPV | Arrange an evaluation for positional testing and appropriate repositioning treatment |
| Wooziness or dim vision just after standing | Dehydration or orthostatic blood pressure drop | Sit or lie down, review fluid intake, and have blood pressure and medications checked |
| Dizziness with sweating, shaking, hunger, or confusion | Low blood sugar | Check glucose if possible and follow your prescribed hypoglycemia plan |
| Dizziness after repeated vomiting or diarrhea | Fluid or electrolyte loss | Contact a clinician promptly, especially if you cannot keep fluids down or urination decreases |
| Spinning with ringing, ear pressure, or hearing change | Inner-ear disorder | Seek prompt medical evaluation and mention the hearing symptoms |
| New severe imbalance with weakness, facial droop, speech trouble, or double vision | Possible stroke or another neurologic emergency | Call 911 |
| Dizziness with facial or throat swelling, hives, or trouble breathing | Possible serious allergic reaction | Call 911 |
A symptom log can be surprisingly useful. Record the GLP-1 product and dose, injection day, any recent increase, the time symptoms started, meals, fluid intake, vomiting or diarrhea, glucose if available, blood pressure if available, and how long the episode lasted.
What to do if vertigo starts after a GLP-1 dose?
First, prevent a fall. Sit or lie down, avoid driving, and do not use stairs, ladders, or machinery until the feeling has fully cleared. Then look for clues that point to low glucose, fluid loss, a blood pressure drop, or an emergency.
Use this practical sequence:
-
- Get stable. Sit or lie somewhere safe. If you feel faint, do not try to walk it off.
-
- Name the sensation. Is the room spinning, are you close to fainting, or are you simply unsteady?
-
- Check glucose if you have diabetes or use glucose-lowering medicine. If it is below your personal threshold, use your treatment plan. NIDDK advises 15 to 20 grams of glucose or fast-acting carbohydrate for a reading below target, followed by another check after 15 minutes.
-
- Think about fluids and stomach symptoms. Take small sips if you can and if you do not have a medical fluid restriction. Inability to keep liquids down needs medical advice.
-
- Check blood pressure if you have a monitor and can do so safely. Record the reading and whether the symptoms followed standing. Do not keep standing for repeated checks if you may faint.
-
- Contact the prescriber for repeated, persistent, or severe symptoms. Contact them sooner if the problem began after a dose increase, caused a fall, or interferes with walking.
Do not take an extra dose, speed up the titration, or change insulin or blood pressure medicine on your own. If symptoms are continuing as the next GLP-1 dose approaches, ask the prescriber for instructions before taking or skipping it.
When should dizziness or vertigo be treated as an emergency?
Call 911 for sudden severe dizziness or loss of balance with signs of stroke, a serious heart problem, a seizure, or a severe allergic reaction.
The CDC includes sudden trouble walking, dizziness, loss of balance, and loss of coordination among possible stroke signs. Its current stroke guidance urges immediate action because treatment is time-sensitive.
Get emergency help for new severe dizziness or vertigo with any of the following:
-
- facial droop or one-sided arm or leg weakness
- trouble speaking, understanding speech, or new confusion
- double vision, sudden vision loss, or inability to walk
- a sudden severe headache
- chest pain, trouble breathing, or a rapid or irregular heartbeat
- fainting or a seizure
- swelling of the face, lips, tongue, or throat
- ongoing vomiting with severe weakness or signs of dehydration
Mayo Clinic also recommends emergency care for new severe dizziness with neurologic, heart, breathing, fainting, hearing, or persistent-vomiting symptoms.
For someone with diabetes, severe low blood sugar that causes unconsciousness, a seizure, or inability to swallow is also an emergency. Use glucagon if it has been prescribed and someone knows how to give it, and call 911. Never give food or drink to an unconscious person.
How to treat vertigo or dizziness during GLP-1 treatment?
Treatment depends on the cause.
Should you stop your GLP-1 medication?
Do not stop solely because of one mild dizzy spell without first checking for common causes. Repeated vertigo, fainting, a fall, inability to walk normally, or symptoms that return after each dose deserve prompt review before the next dose.
Depending on the findings, the prescriber may decide to keep the dose steady longer, delay an increase, reduce the dose, adjust insulin or blood pressure medicines, treat a separate vestibular disorder, switch products, or discontinue the GLP-1 drug. The safest choice depends on why you take it, how serious the symptoms are, and what other treatment options you have.
For emergency symptoms, call 911 immediately.
If you suspect a serious drug reaction, you or your clinician can also submit a report through FDA MedWatch. A report helps safety monitoring, but it does not prove that the medicine caused the event.
Frequently Asked Questions
Articles you may also be interested in
